CMT trades 3.1% below Wall Street's consensus target of $24.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CMT achieves its forward estimates and maintains a stable P/E multiple of 21.8x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Core Molding Technologies, Inc. (CMT) has a Wall Street consensus price target of $24.00, based on estimates from 2 covering analysts. With the stock currently trading at $23.28, this represents a potential upside of +3.1%. The company has a market capitalization of $214M.
Analyst price targets range from a low of $24.00 to a high of $24.00, representing a 0% spread in expectations. The median target of $24.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CMT trades at a trailing P/E of 18.0x and forward P/E of 21.8x. The forward PEG ratio of 3.85 reflects a premium valuation. Analysts expect EPS to grow -3.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $22.42, with bear and bull scenarios of $14.12 and $29.54 respectively. Model confidence stands at 47/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
UFPTUFP Technologies, Inc. | $2.0B | $264.11 | $298.00 | +12.8% | Buy | 27.8x | 2 |
TREXTrex Company, Inc. | $4.9B | $47.11 | $49.25 | +4.5% | Hold | 28.1x | 34 |
LYTSLSI Industries Inc. | $807M | $24.91 | $28.50 | +14.4% | Buy | 22.2x | 5 |
MTRNMaterion Corporation | $5.1B | $247.20 | $161.00 | -34.9% | Buy | 38.5x | 10 |
ATKRAtkore Inc. | $2.3B | $69.26 | $79.50 | +14.8% | Hold | 12.9x | 11 |
ESABESAB Corporation | $5.7B | $94.02 | $138.25 | +47.0% | Buy | 16.3x | 10 |
LYBLyondellBasell Industries N.V. | $17.6B | $54.60 | $79.40 | +45.4% | Hold | 6.0x | 39 |
HUNHuntsman Corporation | $1.9B | $10.97 | $13.60 | +24.0% | Hold | — | 33 |
EMNEastman Chemical Company | $8.0B | $69.62 | $79.44 | +14.1% | Buy | 10.9x | 35 |
PCARPACCAR Inc | $65.5B | $124.46 | $128.40 | +3.2% | Hold | 21.9x | 45 |
Quick answers to the most common questions about buying CMT stock.
The consensus price target for CMT is $24, close to the current price of $23.28 (3.1% implied move). Based on 2 analyst estimates, the stock appears fairly valued near current levels.
CMT has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $24 implies 3.1% upside from current levels.
CMT trades at a forward P/E of 21.757x, representing a moderate valuation. With analysts targeting $24 (3.1% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $24 for CMT, while the most conservative target is $24. The consensus of $24 represents the median expectation. Our quantitative valuation model projects a bull case target of $30 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CMT is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CMT stock forecast based on 2 Wall Street analysts shows a consensus price target of $24, with estimates ranging from $24 (bear case) to $24 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $22, with bear/bull scenarios of $14/$30.
Our quantitative valuation model calculates CMT's fair value at $22 (base case), with a bear case of $14 and bull case of $30. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.
CMT trades at a forward P/E ratio of 21.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.0x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
CMT appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $24 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CMT analyst price targets range from $24 to $24, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $24 consensus represents the middle ground. Our model's $14-$30 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.